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MICALs, a Family of Conserved
Flavoprotein Oxidoreductases, Function
in Plexin-Mediated Axonal Repulsion
terized vertebrate-secreted semaphorin, is a potent axo-
nal repellent for a variety of neurons in vitro, and in vivo
serves as a chemorepellent essential for the establish-
ment of many axonal pathways (Raper, 2000). Similarly,
the related Drosophila-secreted semaphorin Sema-2a is
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725 North Wolfe Street expressed on developing muscles and regulates motor
axon pathfinding as a target-derived chemorepellentBaltimore, Maryland 21205
(Matthes et al., 1995; Winberg et al., 1998a).
Insight into how semaphorins signal repulsive guid-
ance comes from work showing that plexins, a largeSummary
family of evolutionarily conserved transmembrane pro-
teins, serve as signal-transducing receptors for bothMembers of the semaphorin family of secreted and
membrane bound and secreted semaphorins (Tamag-transmembrane proteins utilize plexins as neuronal
none and Comoglio, 2000). The four classes of plexinsreceptors to signal repulsive axon guidance. It remains
include proteins that have been found to associate di-unknown how plexin proteins are directly linked to the
rectly with members of five different semaphorinregulation of cytoskeletal dynamics. Here, we show
classes. In the Drosophila nervous system, plexin Athat Drosophila MICAL, a large, multidomain, cytosolic
(PlexA) is a functional receptor in vivo for Sema-1a-protein expressed in axons, interacts with the neuronal
mediated motor axon repulsion (Winberg et al., 1998b).plexin A (PlexA) receptor and is required for Semapho-
In vertebrates, repulsion mediated by class 3 secretedrin 1a (Sema-1a)-PlexA-mediated repulsive axon guid-
semaphorins is dependent on plexin function both inance. In addition to containing several domains known
vitro and in vivo (Cheng et al., 2001; reviewed in Tamag-to interact with cytoskeletal components, MICAL has
none and Comoglio, 2000). However, repulsive guidancea flavoprotein monooxygenase domain, the integrity
mediated by class 3 semaphorins, including Sema3Aof which is required for Sema-1a-PlexA repulsive axon
and Sema3F, requires a holoreceptor complex that in-guidance. Vertebrate orthologs of Drosophila MICAL
cludes a ligand binding obligate coreceptor, neuropilin-are neuronally expressed and also interact with verte-
1 or neuropilin-2, and a class A plexin. Plexin cytoplasmicbrate plexins, and monooxygenase inhibitors abrogate
domains are highly conserved and, for certain A classsemaphorin-mediated axonal repulsion. These results
plexins, have been shown to be responsible for signalingsuggest a novel role for oxidoreductases in repulsive
semaphorin-mediated repulsive axon guidance (Chengneuronal guidance.
et al., 2001; Takahashi and Strittmatter, 2001).
The repulsive nature of semaphorin signaling medi-Introduction
ated by plexin receptors is due to the modification of
the growth cone cytoskeleton. For example, followingDuring neural development, axons reach their appro-
exposure to secreted Sema3A, growth cones undergopriate targets by interpreting a myriad of guidance cues
rapid collapse, which is accompanied by the depolymer-present in their environment. Semaphorin proteins, one
ization of F actin and decreased ability to polymerizeof the largest families of guidance cues, are known to
new F actin (Fan et al., 1993). Several modulators ofinfluence axon pathfinding, fasciculation, branching,
cytoskeletal dynamics have been implicated in this pro-and neuronal cell migration (He et al., 2002; Raper, 2000).
cess including Rho family GTPases, p21-activated ki-A chemorepulsive role in axon guidance has been exten-
nase (PAK), and LIM kinase (Liu and Strittmatter, 2001;sively demonstrated both in vitro and in vivo for many
Whitford and Ghosh, 2001). In addition, members of thesemaphorins, but they also mediate attractive neuronal
collapsin response mediator protein (CRMP) family, theguidance.
Ig superfamily protein L1, intracellular levels of cGMP,The seven classes of semaphorins include both trans-
and the catalytically inactive receptor tyrosine kinasemembrane and secreted proteins and are evolutionarily
family member offtrack (OTK) have also been implicatedconserved structurally and, in many cases, functionally
in transducing semaphorin repulsive guidance (He etfrom invertebrates to vertebrates (Semaphorin Nomen-
al., 2002). It remains unknown, however, how plexinsclature Committee, 1999). For example, the transmem-
directly regulate the activity of these signaling moleculesbrane semaphorin Sema-1a in Drosophila is present on
in order to modulate cytoskeletal dynamics.developing motor axons and acts as a repellent to regu-
We show here that a family of flavoprotein monooxy-late motor axon fasciculation in vivo (Yu et al., 1998). The
genases, the MICALs, contains members that directlyrelated vertebrate transmembrane semaphorin Sema6A
associate with plexins and are required for semaphorin-also functions as a repellent for axons of sympathetic
mediated repulsive axon guidance. Further, MICAL pro-neurons in vitro (Xu et al., 2000). Sema3A, a well-charac-
teins contain multiple domains that are known to be
important for interactions with actin, intermediate fila-1Correspondence: kolodkin@jhmi.edu
ments, and cytoskeletal-associated adaptor proteins.2 Present address: Division of Basic Sciences, Fred Hutchinson Can-
Therefore, MICALs are excellent candidates for directlycer Research Center, 1100 Fairview Ave. N., Seattle, Washington,
98109. mediating the cytoskeletal alterations characteristic of
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Figure 1. Molecular Characterization of Dro-
sophila MICAL, MICAL Expression in Dro-
sophila Embryonic Motor Axons, and Coim-
munoprecipitation of MICAL with Neuronal
PlexA
(A) The MICAL locus. Variable exons are indi-
cated with asterisks and produce (1) a “long,”
(2) a “medium” (spliced out exon is shown in
red), and (3) a “short” isoform (spliced out
exons shown in green). The regions corre-
sponding to clones 23 and 151 are shown.
(B) MICAL is characterized by flavin adenine
dinucleotide (FAD) consensus binding motifs
(GXGXXG, DG, and GD motifs), a calponin
homology domain, a LIM domain, a proline-
rich region, and a coiled-coil motif.
(C and D) Stage 15 whole-mount Drosophila
embryos following in situ hybridization with
antisense probes to MICAL (A) and PlexA (B).
Anterior to left. Ventral nerve cord (VNC).
(E and F) Filleted stage 15/16 Drosophila em-
bryos immunostained with MICAL antiserum
(anterior is to the left). The region outlined in
(E) is shown in higher power in (E1) from a
similarly staged embryo. MICAL decorates
motor neuron cell bodies (arrows) and their
bundled axons (asterisks) as they exit the
ventral nerve cord and innervate their muscle
targets (arrowheads). Abbreviations: 6, 7,
muscles 6 and 7; I, ISN; b, ISNb; and a, SNa.
(G) MICAL and PlexA proteins associate in
Drosophila neurons in vivo. Embryonic ly-
sates derived from embryos with neuronally
expressed HA-PlexA(input) were immunopre-
cipitated (IP) using HA antibodies and immu-
noblotted with antibodies directed against
HA (left), MICAL (middle), or Enabled (right).
Robust coimmunoprecipitation of MICAL
(arrows), but not Ena (arrowhead), is ob-
served with HA (PlexA) antibodies. Molecular
weight is in kilodaltons. Scale bar equals 30
m (C and D); 18 m (E); 12 m (F).
semaphorin signaling and provide novel targets for the S1). Based on analysis of isolated cDNAs and Western
analysis (see Supplemental Figure S2D), there are atattenuation of axonal repulsion.
least three MICAL isoforms (“long,” “medium,” and
“short” variants; Figure 1A).Results
Drosophila MICAL is named for its recently character-
ized vertebrate ortholog, MICAL-1 (for molecule inter-MICAL Is a Large, Cytosolic, Multidomain Protein
that Interacts with Drosophila Plexin A acting with CasL), which has been shown to associate
with CasL and vimentin in nonneuronal cells (Suzuki etTo identify mediators of semaphorin-dependent repul-
sive axonal guidance, we used the terminal highly con- al., 2002). Within the plexin-interacting region in the C
terminus identified in our screen, there is a predictedserved “C2” portion of the PlexA cytoplasmic domain to
search for interacting proteins encoded by a Drosophila heptad-repeat, coiled-coil structure (Figure 1B; data not
shown). Interestingly, this region of MICAL shares aminoembryonic (0–24 hr) yeast two-hybrid cDNA library (see
Supplemental Figures S1A–S1C at http://www.cell.com/ acid similarity with several other coiled-coil domain-
containing proteins including a portion of the  domaincgi/content/full/109/7/887/DC1). Although the strongest
interactors we identified (clones 151 and 23) (Figure 1A) found in the Ezrin, Radixin, and Moesin (ERM) proteins
(22% identity; data not shown; Bretscher et al., 2000).interacted with PlexA in yeast, they did not interact with
the C2 region of the other Drosophila plexin, PlexB (see N-terminal to this domain there is a region rich in pro-
lines, and the last four amino acids of MICAL (ESII) areSupplemental Figure S1B). Extensive molecular analysis
demonstrated that the Drosophila gene defined by a PDZ protein binding motif (Harris and Lim, 2001). There
are two regions of varying length, with no significantclones 23 and 151, which we have called MICAL (see
below), covers 41 kb of genomic sequence and has similarity to other proteins, which appear to determine
the size of the different MICAL proteins (Figure 1B).at least 25 exons (Figure 1A; see Supplemental Figure
MICAL Oxidoreductases and Plexin Repulsion
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MICAL has a single LIM domain (Figure 1B; data not control of an upstream activator sequence (UAS) (Brand
and Perrimon, 1993) and crossed them to flies that ex-shown), a protein-protein interaction module found in a
variety of proteins involved in signal transduction cas- press the GAL4 transcription factor in all neurons (Elav-
GAL4). In lysates from the resulting embryos, we ob-cades and in cytoskeletal organization (Bach, 2000), and
also a single calponin homology (CH) domain (Figure1B; served robust coimmunoprecipitation of MICAL using
HA antibodies (Figure 1G) and also reciprocal coimmu-data not shown), a domain also found in cytoskeletal and
signal transduction proteins and known to be involved in noprecipitation of HA-PlexA using MICAL-CT antibodies
(data not shown). The “large” MICAL isoform is the pre-actin filament binding (Gimona et al., 2002). The MICAL
N-terminal 500 aa is highly conserved among MICAL- dominant variant observed to be associated with neu-
ronally expressed HA-PlexA, which may reflect tissue-related proteins (see below) but is unique over its entire
length in comparison to other proteins. specific expression of this isoform in neurons. MICAL
coimmunoprecipitation appears specific since enabled
(Ena), a neuronally expressed cytosolic protein, was notMICAL Is Expressed on Drosophila
coimmunoprecipitated by HA antibodies in similar ex-Embryonic Motor and CNS Axons
periments (Figure 1G), and Unc5, a neuronally expressedand Coimmunoprecipitates with PlexA
transmembrane receptor, was not coimmunoprecipi-In situ hybridization analysis using RNA probes corre-
tated by MICAL-CT antibodies (data not shown).sponding to the N or C terminus of MICAL shows that
MICAL and PlexA have similar patterns of embryonic
mRNA expression. During early Drosophila develop- A MICAL Loss-of-Function Mutant Demonstrates
that MICAL Is Required for Motorment (stages 7–8), both are expressed in the ventral
neurogenic region and in many nonneuronal tissues (in- Axon Pathfinding
To determine whether MICAL functions in vivo to propa-cluding developing mesoderm, cells surrounding the ce-
phalic furrow and amnioproctodeal invagination, and in gate Sema-1a-mediated motor axon guidance, we per-
formed detailed genetic analyses of MICAL gain- andgut primordia). This nonneuronal expression is also seen
later in embryonic development (stages 11–17), where loss-of-function mutants. We generated a small, tracta-
ble deficiency (called Df(3R)swp2MICAL; see Supplementalboth are present within the anterior and posterior midgut
primordia, the visceral musculature, and weakly in so- Figure S2 at http://www.cell.com/cgi/content/full/109/
7/887/DC1) that removes 170 kb that includes the MI-matic musculature. During axonal pathfinding (stage 13
onward), both are expressed within the developing brain CAL locus and 6 other genes. Western blot analysis
on lysates from embryos homozygous for Df(3R)swp2MICALand ventral nerve cord in most, if not all, CNS neurons
(Figures 1C and 1D; data not shown), but MICAL, like demonstrates a loss of all MICAL protein (Supplemental
Figure S2D), and no MICAL immunostaining is observedSema1a and PlexA, is not highly expressed in peripheral
sensory neurons. in these embryos (data not shown). These data, in com-
bination with rescue experiments using a MICAL cDNAWestern blot analysis using a polyclonal antibody di-
rected against the MICAL C terminus (MICAL-CT) re- (see below), define the small deficiency Df(3R)swp2MICAL
as a MICAL null allele. Df(3R)swp2MICAL homozygotesvealed prominent bands at 530 kDa, 330 kDa, 300 kDa,
200 kDa, and 125 kDa in lysates from wild-type embryos survive into larval stages and have no overt morphologi-
cal abnormalities (see Supplemental Figure S2).which increase in intensity in lysates from embryos
harboring a chromosomal duplication that includes the If MICAL functions in Sema-1a/PlexA-dependent re-
pulsive axon guidance, then MICAL LOF mutants shouldMICAL locus (see Supplemental Figure S2D at http://
www.cell.com/cgi/content/full/109/7/887/DC1). The three exhibit motor axon guidance defects similar to the dis-
tinct and highly penetrant defects seen in Sema1a andlargest protein bands correspond to the predicted mo-
lecular weights of the three MICAL cDNAs (Figures 1A). PlexA LOF mutants. The development of the stereotypic
pattern of neuromuscular connectivity in embryonicThese bands were not present in embryonic lysates ob-
tained from embryos harboring a deficiency that in- Drosophila abdominal segments is observed with anti-
fasciclin II (mAb 1D4) staining of stage 16/17 embryoscludes the MICAL locus (see below and Supplemental
Figure S2D). (VanVactor et al., 1993). Motor axons initially exit the
CNS as part of either the intersegmental nerve (ISN) orMICAL protein is present in neuronal cell bodies, along
axons, and in growth cones (Figures 1E and 1F; data the segmental nerve (SN). They are then guided into five
major nerve branches (the ISN, ISNb, ISNd, SNa, andnot shown). MICAL immunostaining first appears in the
nervous system at stage 13 and labels motor and CNS SNc), each of which targets different muscle groups
such that individual motor axons eventually innervateprojections, and at later embryonic stages, it is present
on axons that make up all motor axon pathways: the individual target muscles (Landgraf et al., 1997).
In wild-type embryos, the ISNb is formed by ISN axonsintersegmental nerve (ISN), the intersegmental nerves b
and d (ISNb and ISNd), and the segmental nerves a and defasciculating and extending dorsally through the ven-
tral musculature to innervate muscles 6 and 7 and mus-c (SNa and SNc) (Figures 2E and 2F; data not shown).
MICAL immunostaining is also present in segment cles 12 and 13 (Figures 2A and 4E). Axons within the
ISNb pathway in Sema1a or PlexA mutants often fail toboundaries at the position of muscle attachment sites
and at low levels in the lateral cluster of chordotonal defasciculate and innervate their muscle targets (Figure
2B; Table 1; Winberg et al., 1998b; Yu et al., 1998). Inorgans.
To ask whether PlexA and MICAL directly interact in the absence of MICAL, axons within the ISNb show
similar highly penetrant ISNb phenotypes (Figure 2C;neurons, we generated flies that contain a transgene
encoding epitope-tagged PlexA (HA-PlexA) under the Table 1). These phenotypes include the failure of some
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Figure 2. MICAL Is Required for ISNb Path-
way Formation and Interacts Genetically with
Sema1a and PlexA
Abdominal segments of filleted stage 16/17
embryos stained with mAb 1D4 to reveal mo-
tor axons. Ventral muscles 6, 7, 12, and 13
and the intersegmental nerve (ISN) are la-
beled. Anterior, left; dorsal, up.
(A) Axons comprising the ISNb (b) in a wild-
type embryo defasciculate from the ISN and
grow dorsally through the ventral muscula-
ture to innervate muscles 6/7 and muscles
12/13 (arrows).
(B) Axons within the ISNb of a Sema1a mutant
embryo often fail to innervate muscles 6/7
and 12/13 (arrows).
(C) Axons within the ISNb of a homozygous
MICAL mutant (Df(3R)swp2MICAL) fail to inner-
vate muscles 6/7 and 12/13 (arrows). In the
left hemisegment, some axons bypass mus-
cles 6/7 and then stall prior to reaching mus-
cles 12/13.
(D and E) MICAL interacts genetically with
Sema1a and PlexA. Axons within the ISNb of
an embryo transheterozygous for MICAL and
sema1a (sema1a/;Df(3R)swp2MICAL/) or MI-
CAL and PlexA (Df(3R)swp2MICAL/;
Df(4)C3PlexA/) often fail to innervate muscles
6/7 and 12/13 (arrows). Some ISNb axons fail
to defasciculate from the ISN and exhibit a
bypass phenotype (arrowhead, [D]).
(F) Expression of MICAL in all neurons res-
cues the ISNb defects observed in MICAL
mutant embryos. Axons within the ISNb in-
nervate muscles 6/7 and 12/13 normally (e.g.,
arrows). Scale bar equals 16 m and can be
applied to Figures 3 and 4.
or all axons to defasciculate from the ISN, stalling of gesting that MICAL primarily functions during Drosoph-
ila neural development in PlexA signaling events.axons within the ISNb following defasciculation from the
ISN, ISNb axons bypassing their target muscle groups, and We restored MICAL expression in homozygous
Df(3R)swp2MICAL embryos using one copy of the trans-greatly reduced or absent innervation of target muscles.
Axons within the SNa pathway in MICAL mutants also genic construct UAS-MICAL under the control of the
neuron-specific driver Elav-GAL4. Due to the large sizeexhibit highly penetrant defects similar to those ob-
served in both Sema1a mutants and PlexA mutants. In of the MICAL protein, we attempted our rescue using
the smallest MICAL isoform—the 300 kDa “small” formwild-type embryos, SNa axons defasciculate from the
SN and extend through the ventral musculature as a (Figure 1A). The level of neuronal MICAL expression
observed by immunostaining with MICAL antibodies insingle tightly fasciculated bundle (Figure 3A). At the dor-
sal edge of muscle 12, SNa axons defasciculate to give three independent MICAL transformants was somewhat
lower than wild-type levels (data not shown). Neuronalrise to a dorsal (D) and lateral (L) branch. Axons within
the dorsal branch extend dorsally between muscles 22 MICAL expression did not rescue the adult lethality in
Df(3R)swp2MICAL homozygotes, suggesting a requirementand 23 and then make two characteristic turns, continu-
ing farther dorsally between muscles 23 and 24 (Figures for the MICAL “long” form, other genes within the
Df(3R)swp2MICAL deficiency, and/or MICAL in nonneu-3A and 4E). In Sema1a and PlexA mutants, SNa axons
within the dorsal branch often stall near muscle 12 and ronal cells for adult viability. We did, however, observe
that neuronal MICAL expression in homozygousfail to reach the dorsal-most portion of their trajectory
(Figure 3B; Table 1; Winberg et al., 1998b; Yu et al., Df(3R)swp2MICAL embryos almost completely rescues
embryonic ISNb and SNa motor axon guidance defects1998). MICAL mutants exhibit similar, highly penetrant,
SNa stall phenotypes (Figures 3C; Table 1). MICAL mu- (Table 1; Figures 2F, 3F, and 4E) and CNS longitudinal
connective defects (data not shown). Therefore, axontants also exhibit prominent guidance defects in axons
that give rise to the ISNd, SNc, TN, and the third most guidance phenotypes observed in the MICAL deficiency
Df(3R)swp2MICAL result from a lack of neuronal MICAL.lateral fasciclin II—positive CNS longitudinal connective
(Figure 2C; data not shown)—defects that have been
observed in Sema1a and PlexA mutants (Winberg et al., MICAL Genetically Interacts with Sema1a
and PlexA1998b; Yu et al., 1998; data not shown). In MICAL LOF
mutant embryos, we did not see additional phenotypes To address whether MICAL functions in the same signal-
ing pathway with PlexA to mediate Sema-1a-mediatedbeyond those seen in PlexA and Sema1a mutants, sug-
MICAL Oxidoreductases and Plexin Repulsion
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Table 1. Axon Guidance Phenotypes (ISNb and SNa Phenotypes)
Abnormal Abnormal Abnormal
ISNb Muscle 6/7 Muscle 12/13
Genotype (Hemisegments) Bypassa(x) Innervationb(y) Innervationb SNa Pathwayc(z)
Controls
/ (wild type) (n  120) 0% 1.7% 2.5% 10.0%
Elav-GAL4/ (n  130) 0% (0%) 1.5% (0%) 4.6% 8.5% (0%)
Elav-GAL4/Elav-GAL4 (n  109) 0% (0%) 2.8 (0%) 8.2% 12.8% (0%)
Df(3R)swp2MICAL/ (n  110) 0% 3.6% 7.2% 7.3%
Sema1aP1/ (n  110) 0% 2.7% 8.1% 9.1%
Df(4)C3PlexA/ (n  101) 0% 1.0% 3.0% 12.0%
Loss of Function
Df(3R)swp2MICAL/Df(3R)swp2MICAL (n  103) 1.0% 68.9% 57.3% 81.2%
Sema1aP1/Sema1aP1 (n  97) 5.2% 47.4% 77.3% 85.7%
Df(4)C3PlexA/Df(4)C3PlexA (n  148) 4.1% 60.8% 47.3% 74.3%
Elav-GAL4/UASMICAL; 0% 5.8% 13.0% 20.3%
Df(3R)swp2MICAL/Df(3R)swp2MICAL (n  138)
UASMICALG→W/; Elav-GAL 4/; 0% 67.2% 68.6% 69.7%
Df(3R)sup2MICAL/Df(3R)swp2MICAL (n  137)
Genetic Interactions
Sema1aP1/;Df(3R)swp2MICAL/ (n  110) 3.6% 32.7% 37.3% 51.8%
Df(3R)swp2MICAL/;Df(4)C3PlexA/ (n  105) 0% 41.9% 33.0% 44.6%
Sema1aP1/;Df(4)C3PlexA/ (n  108) 0% 32.4% 39.8% 68.5%
Sema1aP1,Elav-GAL4/; 0% 6.1% 6.1% 9.2%
UASMICAL/Df(3R)swp2MICAL (n  99)
Gain of Function
Elav-GAL4/Elav-GAL4; 2.1% (50%) 32.0% (3.2%) 48.5% 46.4% (2.2%)
UASMICALMyr-CT/UASMICALMyr-CT (n  97)
UASMICAL/UASMICAL; 0.8% (100%) 44.2% (59.6%) 50.0% 38.0% (71.4%)
Elav-GAL4/Elav-GAL4 (n  130)
UASMICALG→W/; Elav-GAL4/ (n  170) 2.4% (100%) 36.7% (43.5%) 44.4% 48.5% (37.8%)
Description of phenotypes is as follows (x, y, and z indicate percent of defects in a, b, and c, respectively).
a Failure of all ISNb axons to defasiculate from the ISN.
b ISNb axons stalling, bypassing targets, absent or decreased muscle innervation.
c Failure to make the two characteristic turns between muscles 22 and 23 and muscles 23 and 24.
x All ISNb axons follow the ISNd or SNc, or ISNb axons remain fasciculated with the ISN but ultimately wander in the lateral muscle fields or
project back to innervate ventral muscles.
y Increased (long or excessively thick) muscle innervation, excessive branching, or projecting into abnormal target fields.
z Fasciculation with the ISN, premature branching, following abnormal pathways, or termination on wrong muscles.
repulsive axon guidance, we employed classical genetic background and observed that neuronal MICAL expres-
sion rescues both the ISNb and SNa phenotypes in theseinteraction analysis by asking whether heterozygosity
at both MICAL and PlexA, or MICAL and Sema1a, re- transheterozygous embryos (Table 1). These results
support the idea that MICAL and PlexA function in thesulted in phenotypes not observed in either heterozy-
gote alone. MICAL, PlexA, or Sema1a heterozygous em- same signaling pathway to guide motor axons.
bryos show no motor axon guidance defects (Table 1).
Embryos heterozygous for both Sema1a and PlexA MICAL Gain-Of-Function Axon
Guidance Phenotypes(Sema1a/;Df(4)C3PlexA/) show highly penetrant axon
guidance defects similar to those observed in homozy- To complement MICAL LOF analysis, we asked whether
MICAL GOF mutants exhibit motor axon guidance phe-gous Sema1a or PlexA mutants (Table 1; Winberg et
al., 1998b). Embryos heterozygous for both MICAL and notypes similar to those observed in PlexA GOF mutants
(Winberg et al., 1998b). We overexpressed MICAL in allSema1a, or heterozygous for both MICAL and PlexA,
exhibit axon guidance phenotypes similar to those seen neurons in a wild-type background using the GAL4-UAS
system, and one or two copies of our MICAL rescuein Sema1a/;Df(4)C3PlexA/ embryos, and these are seen
at approximately equal penetrance (Table 1). For exam- construct leads to highly penetrant motor axon guidance
phenotypes (Table 1; data not shown). GOF phenotypesple, the ISNb and SNa of Sema1a/;Df(3R)swp2MICAL/
or Df(3R)swp2MICAL/;Df(4)C3PlexA/ embryos exhibit resulting from one copy of the MICAL rescue construct
in a wild-type background can be suppressed in aguidance errors at specific choice points similar to those
seen in homozygous PlexA, Sema1a, or MICAL mutant Df(3R)swp2MICAL genetic background (Table 1; data not
shown). GOF defects in some cases are quite similar toembryos (Figures 2D, 2E, 3D, 3E, and 4E). We reintro-
duced one copy each of both the UAS-MICAL and Elav- the defects we observe in MICAL mutants and defects
reported in PlexA GOF mutants (Winberg et al., 1998b).GAL4 transgenes into the Sema1a/;Df(3R)swp2MICAL/
Cell
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Figure 3. MICAL Is Required for Proper For-
mation of the SNa Pathway and Interacts Ge-
netically with Sema1a and PlexA
Abdominal segments of filleted stage 16/17
embryos stained as in Figure 2. Ventral mus-
cles 12 and 13 and lateral muscles 22, 23,
and 24 are labeled. Anterior, left; dorsal, up.
(A) Axons that make up the SNa in a wild-
type embryo extend through the ventral mus-
culature as a fasciculated bundle (SNa). After
reaching the dorsal edge of muscle 12, axons
within the SNa give rise to a dorsal (D) and
lateral (caudal) (L) branch. Axons within the
dorsal branch extend dorsally between mus-
cles 22 and 23 and then make two character-
istic turns (arrows) and continue extending
dorsally between muscles 23 and 24.
(B) Axons within the SNa of a Sema1a mutant
embryo fail to make the two characteristic
turns and instead stall just dorsal to muscle
12 between muscles 22 and 23 (arrows).
(C) Axons within the SNa of a MICAL mutant
(Df(3R)swp2MICAL) stall just dorsal to muscle
12 (arrows).
(D and E) MICAL interacts genetically with
Sema1a and PlexA. Axons within the SNa of
an embryo transheterozygous for MICAL and
Sema1a (sema1a/;Df(3R)swp2MICAL/) (D)
or MICAL and PlexA (Df(3R)swp2MICAL/;
Df(4)C3PlexA/) (E) often fail to reach their dor-
sal targets (arrows).
(F) Expression of MICAL in all neurons res-
cues the SNa pathfinding defects observed
in MICAL mutant embryos. Axons within the
SNa project normally to their dorsal muscle
targets, making both characteristic turns
(arrows).
However, a large fraction of these MICAL GOF motor The MICALs Are a Family of Neuronally Expressed,
Plexin-Interacting Proteins Conservedaxon guidance phenotypes are consistent with in-
creased defasciculation (Table 1), as similarly described from Flies to Mammals
MICAL proteins have conserved protein domains withfor the PlexA GOF mutants. For example, ISNb axons
were often seen to abnormally leave the ISNb and pro- identical organization in all family members and a high
degree of amino acid identity among these domains inject incorrectly within the ventral musculature (Figures
4A and 4E; Table 1). Likewise, some SNa axons defasci- different MICALs (Figure 5A). Suzuki et al. (2002) identi-
fied MICAL-1 and a partial sequence of MICAL-2. Weculated at incorrect locations and projected to inappro-
priate areas (Figure 4B; Table 1). Therefore, MICAL GOF have found that there is one MICAL in Drosophila and
three mammalian MICALs. The MICALs appear uniquemutants exhibit phenotypes similar to PlexA GOF mu-
tants (Figure 4E), again suggesting that MICAL partici- with respect to containing both calponin homology (CH)
and LIM domains, in addition to their conserved N- andpates in PlexA-mediated motor axon guidance.
Additional support for MICAL’s role in PlexA signaling C-terminal regions. We have also found a family of
MICAL-like (MICAL-L) proteins, members of which havewas obtained by expressing in all neurons a truncated
MICAL protein consisting only of the MICAL PlexA-inter- a similar organization to MICALs but lack the region
N-terminal to the CH domain (Figure 5B). There is oneacting region (Figure 1B). We targeted this protein to
the cell membrane by introducing an N-terminal myris- MICAL-L protein in Drosophila (D-MICAL-L) and at least
two family members in humans. D-MICAL-L cDNA andtoylation sequence (MICALMyr-CT) and found that neu-
ronally expressed MICALMyr-CT acts in a dominant-nega- genomic DNA sequence information suggest that
D-MICAL-L begins just N-terminal to the CH domain.tive fashion, resulting in axon guidance phenotypes
similar to those observed in MICAL mutants (Figures Analysis of publicly available mammalian cDNA and ge-
nomic sequences suggests that human MICAL-L1 and4C–4E; Table 1; data not shown). We did not observe
prominent GOF phenotypes like those resulting from MICAL-L2 are similar in overall domain organization to
D-MICAL-L and do not contain the highly conservedMICAL or PlexA overexpression (Table1), indicating that
neuronal MICALMyr-CT is likely occluding normal MICAL- 500 aa MICAL N-terminal domain.
To address whether the function of MICALs is con-PlexA associations and therefore MICAL signaling. This
also suggests that the MICAL protein contains domains served in vertebrates, we looked at expression patterns
and interactions with plexins and found that the mRNAdistinct from the PlexA-interacting domain that function
to regulate axonal guidance. of all three rat MICALs shows specific neuronal and
MICAL Oxidoreductases and Plexin Repulsion
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Figure 4. MICAL Gain-Of-Function Axon
Guidance Phenotypes
Abdominal segments of filleted stage 16/17
embryos stained as in Figure 2.
(A and B) MICAL overexpression in all neu-
rons in a wild-type background using the
GAL4-UAS system leads to GOF motor axon
guidance phenotypes including increased
defasciculation of axons of the ISNb and SNa.
Axons were often seen exiting their nerve
prematurely or abnormally (arrowheads) and
projecting inappropriately (e.g., arrows).
Abnormal pathfinding by SNa axons or inap-
propriate innervation of muscle 21 by axons
within the ISN was also observed (thin ar-
row, [B]).
(C and D) Embryos expressing MICALMyr-CT in
all neurons using the GAL4-UAS system ex-
hibit motor axon guidance phenotypes similar
to those observed in MICAL loss-of-function
mutants. Axons within the ISNb fail to prop-
erly innervate muscles 6/7 and 12/13 (arrows,
[C]), and axons within the SNa fail to make
their two characteristic turns and reach their
dorsal muscle targets (arrow, [D]). In these
segments, some ISNb axons (C) are seen to
bypass their muscle targets (arrowheads, [C]).
(E) Schematic representation of MICAL ge-
netic analysis and motor axon phenotypes
(see text).
nonneuronal expression during development (Figures tion of the 500 aa conserved N-terminal region, we noted
a consensus dinucleotide binding sequence, GXGXXG5C–5H; data not shown). For example, MICAL1, MICAL2,
and MICAL3 are expressed in the rat spinal cord, dorsal (Figures 1B and 6A), which is distinct from the sequence
present in classical mononucleotide binding motifs (Eg-root ganglia (DRG), and sympathetic ganglia at embry-
onic days 15 (E15) and E18 in patterns that appear over- gink et al., 1990; Eppink et al., 1997; Schulz, 1992; Wie-
lapping but distinct (Figures 5C–5H). Interestingly, the renga et al., 1986). Further, this region contains three
neuronal expression patterns of individual MICALs are separate motifs found in flavoprotein monooxygenases
similar to those observed for several plexins, as can be (also called hydroxylases), a subclass of oxidoreduc-
seen for PlexA3 and MICAL1 (Figures 5F and 5I; data tases (Eggink et al., 1990; Eppink et al., 1997; Wierenga
not shown). In addition, our results to date indicate that et al., 1986). The amino acid sequence surrounding the
the plexin-interacting domains of human MICAL-1 and GXGXXG motif matches perfectly the consensus se-
mouse MICAL-2 specifically interact with the C2 do- quence for the ADP binding region of flavin adenine
mains of human PlexA3 and mouse PlexA4, respectively, dinucleotide (FAD) binding proteins (Rossmann fold or
and do so as strongly as the orthologous domains of FAD fingerprint 1) (Figures 1B and 6A), and distinguishes
Drosophila MICAL and PlexA (see Supplemental Figure this region from consensus NAD, or NADP binding folds
S1B at http://www.cell.com/cgi/content/full/109/7/ (Vallon, 2000; Wierenga et al., 1986). MICALs also have
887/DC1). a well-conserved GD motif (FAD fingerprint 2) (Figures
1B and 6A) C-terminal to the FAD fingerprint 1 region,
which is important for binding the ribose moiety of FADMICALs Contain an N-Terminal Flavoprotein
(Eggink et al., 1990; Eppink et al., 1997). Finally, MICALsMonooxygenase Domain
have the conserved DG motif (“conserved motif”; Fig-The high degree of conservation of the MICAL N termi-
ures 1B and 6A) between the FAD fingerprint 1 and 2nus among family members (up to 62% identical be-
motifs that has been reported to be involved in bindingtween flies and humans) (Figure 5A) suggests that this
domain is functionally important. Upon closer examina- the pyrophosphate moiety of FAD (Eppink et al., 1997).
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Figure 5. The MICALs Are a Family of Neu-
ronally Expressed Plexin-Interacting Proteins
Conserved from Flies to Mammals
(A) The MICAL family of proteins. Amino acid
identities are indicated among vertebrate
MICALs and Drosophila MICAL (percents
within domains) and between vertebrate MI-
CALs (percents in arrows). The black regions
indicate sequences that are not well con-
served among family members and variable
in length (//). Regions encoded by an ORF
situated in close proximity in the genome
(10 kb) but for which cDNA sequence con-
necting them has not yet been identified are
indicated (dots).
(B) MICAL-like proteins have a similar domain
organization as the MICALs but lack the
N-terminal 500 aa domain. Domain align-
ment and amino acid identity between Dro-
sophila MICAL and MICAL-like proteins is in-
dicated (within domains) and between
MICAL-like proteins (within arrows). Available
D-MICAL-L cDNA and genomic DNA se-
quence information suggests that the
D-MICAL-L protein begins just N-terminal to
the CH domain. Human MICAL-L1 and MI-
CAL-L2 are similar in overall domain organi-
zation to D-MICAL-L and do not contain the
highly conserved 500 aa MICAL N-terminal
domain (dots indicate where molecular analy-
sis is required to conclusively define the
structural features of mammalian MICAL-L
proteins). Abbreviations: P, proline-rich re-
gion; cc, coiled-coil.
(C–H) MICAL family members are expressed
in the developing vertebrate nervous system.
Photomicrographs of adjacent sections
through the thoracic level of the E15 (C–E)
and E18 rat (F–H) spinal cord and dorsal root
ganglia (D) following in situ hybridization with
antisense probes specific for each MICAL are
shown. The insets (F–H) show E18 MICAL ex-
pression in sympathetic ganglia (S) at the
same axial level. MICALs are expressed in
what appear to be overlapping but distinct
patterns.
(I) plexin A3 is expressed in a pattern similar
to MICAL-1, seen here in sections adjacent to
those in (F)–(H) following in situ hybridization
with antisense probes specific for plexin A3.
Abbreviations: VF, ventral funiculus; LF, lat-
eral funiculus; and CC, central canal. Scale
bar equals 150 m (C–E); 225 m (F–I).
Proteins with these consensus FAD binding regions use To ask whether MICAL binds FAD, we made a bacte-
rial fusion protein containing the MICAL flavoproteinFAD in the catalysis of oxidation-reduction reactions.
Flavoprotein monooxygenases are oxidoreductases monooxygenase domain (MICAL-FM). A solution of the
purified MICAL-FM is yellow in color, a characteristic of(enzymes that catalyze oxidation and reduction reac-
tions) that catalyze the insertion of one atom of molecu- flavoproteins. Spectral analysis of purified MICAL-FM
shows that it has an absorption peak at 452 nm and alar oxygen into their substrate using nucleotides as elec-
tron donors (Massey, 1995). These monooxygenases shoulder at 358 nm (Figure 6B). This is similar to the
absorption spectra of FAD itself (450 nm and 360are also defined by their use of FAD as a coenzyme.
Apart from these three consensus regions, monooxy- nm; Macheroux, 1999) and to other related flavoproteins
(e.g., p-hydroxybenzoate hydroxylase [Hosokawa andgenases vary significantly, reflecting the wide range of
enzymes in this family and their variable substrate bind- Stanier, 1966] and GidA [White et al., 2001]), suggesting
that MICAL-FM binds FAD. These results, in combina-ing pockets also encompassed within this domain (Ep-
pink et al., 1997). However, MICALs and other monooxy- tion with the sequence homology, raise the possibility
that MICAL enzymatic activity within the N-terminal con-genases show significant similarity within these three
FAD binding regions and also similar spacing of these served domain serves an integral function in plexin sig-
naling.regions within the monooxygenase domain.
MICAL Oxidoreductases and Plexin Repulsion
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Figure 6. The MICALs Contain Flavoprotein Monooxygenase Domains Required for MICAL Function in Drosophila
(A) MICALs contain three sequence motifs that define them as flavoprotein monoxygenases. An alignment of MICALs with members of the
flavoprotein monooxygenase family is shown in which a plus sign indicates that MICALs match the consensus, an asterisk indicates that
MICALs match the highly important conserved residues, and a dot indicates the conserved spacing of these residues within these motifs.
Sequence coloring is based on ClustalX: light blue, hydrophobic and cysteine residues; purple, acids; green, bases; yellow, proline; and
orange, glycine. MICALs contain a 100% match with the consensus ADP binding region of FAD binding proteins (FAD fingerprint 1), a well-
conserved GD sequence (FAD fingerprint 2), and a well-conserved DG motif: distinguishing features of flavoprotein monooxygenases. The
proline (asterisk) in the FAD fingerprint 2 is also likely to be conserved.
(B) MICAL is a FAD binding protein. A bacterial fusion protein consisting of the Drosophila MICAL flavoprotein monoxygenase (FM) domain
has an absorption peak at 452 nm and a shoulder at 358 nm, consistent with that of free FAD (red line) and similar in shape to spectra from
other flavoproteins.
(C–H) The FAD binding region is necessary for MICAL function. Abdominal segments of filleted stage 16/17 embryos stained with mAb 1D4
to label motor axons within the ISNb and SNa are shown. Ventral muscles 6, 7, 12, and 13 and the intersegmental nerve (ISN) are shown.
Anterior, left; dorsal, up.
(C) Neuronal expression of MICALG→W (see text) fails to rescue MICAL loss-of-function axon guidance defects. MICALG→W was expressed in
all neurons in a MICAL LOF background and no rescue was seen of any MICAL motor or CNS pathfinding defects (e.g., ISNb [arrows]; fusion
of ISNb axons with the ISN [arrowhead]).
(D–H) Overexpression of MICALG→W in all neurons in a wild-type background gives rise to highly penetrant axon guidance phenotypes that
resemble MICAL LOF, GOF, and novel phenotypes not observed in MICAL mutants.
(D) ISNb (arrow) and SNa (arrowhead) phenotypes were consistent with, but often more severe than, MICAL LOF. In this segment, ISNb axons
have fasciculated with the ISN and bypassed their muscle fields; however, at more dorsal regions some of these axons defasciculate from
the ISN and then project into adjacent segments (arrows).
(E and F) ISNb and SNa phenotypes were consistent with, but often more severe than, MICAL GOF phenotypes. ISNb axons are severely
defasciculated and tangled in this segment ([E], arrows and arrowheads), and SNa axons have projected in the wrong direction, into the wrong
muscle fields, and across segment boundaries ([F], arrowheads).
(G and H) Phenotypes unlike PlexA, Sema1a, or MICAL LOF or GOF mutants.
(G) ISNb axons extend the entire length of the cleft between muscles 6 and 7 (arrowheads).
(H) SNa axons project abnormally across the ventral muscle fields and wander in circles (arrowheads, bottom) prior to defasciculating (arrows)
and projecting dorsally where they appear to refasciculate in the vicinity of their correct pathways (arrowhead, top). Scale bar equals 24 m
(C) and 27 m (D).
An Intact FAD Binding Motif Is Required for MICAL MICALG→W transgene were generated, and immunohisto-
chemical and Western analyses confirmed that MICALG→WMotor Axon Guidance Functions
The glycine residues within the GXGXXG motif of FAD was expressed at levels comparable to those of our
wild-type “short” MICAL variant that we used to rescuebinding proteins are essential for allowing the FAD bind-
ing and enzymatic activity (Wierenga et al., 1986; Dym MICAL mutant motor axon guidance phenotypes (data
not shown). Unlike neuronal expression of MICAL in aand Eisenberg, 2001). To test the necessity of MICAL
FAD binding and potential enzymatic activity for plexin- homozygous Df(3R)swp2MICAL mutant background,
which rescues all ISNb and SNa defects, one copy ofmediated repulsive axon guidance, we mutated the
three glycine residues within the FAD fingerprint 1 motif the neuronal MICALG→W rescues none of these defects
(e.g., Figure 6C; Table 1). This strongly suggests thatof MICAL to tryptophan (GAGPCGL→WAWPCWL). Similar
mutations in related flavin-containing monooxygenases activity of the MICAL monooxygenase domain is neces-
sary for normal MICAL function.disrupt FAD binding but do not alter the overall structure
of the protein (Kubo et al., 1997; Lawton and Philpot, Since MICALG→W contains an intact plexin-interacting
domain but is functionally inactive, we predicted that it1993; Wierenga et al., 1986). The resulting construct,
MICALG→W, was used for in vivo neuronal expression would exert a dominant-negative effect on motor axon
projections in a wild-type genetic background, bindingin Drosophila. Transgenic flies containing the UAS-
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to PlexA but blocking signaling in a manner similar to our similar to EGCG but a poor inhibitor of SE (Abe et al.,
2000b), had a similar effect on Sema3A-mediated repul-MICALMyr-CT construct. When one copy of the MICALG→W
reporter construct was used to express MICALG→W in all sion. Like EGCG, EC was capable of completely neu-
tralizing Sema3A-dependent repulsion in a dose-depen-neurons in a wild-type genetic background, we ob-
served highly penetrant ISNb, SNa, and CNS longitudinal dent manner, but a much higher EC concentration was
required (Figures 7E and 7G). To address the possibilityconnective defects (Figures 6D–6H; Table 1; data not
shown), providing further evidence that MICALG→W is be- that a general inhibition of oxidation-reduction mecha-
nisms by these reagents underlies this attenuation ofing expressed neuronally and is likely able to bind PlexA.
However, though many of these defects resemble phe- Sema3A repulsion, we asked whether selective inhibi-
tors of other redox enzymes present in neurons had anynotypes observed in Sema1a, PlexA, or MICAL LOF mu-
tants (Table 1), a significant fraction (ISNb, 44%; SNa, effect on Sema3A-mediated repulsion. We did not see
attenuation of Sema3A-mediated axonal repulsion using38%) were strikingly distinct (Table 1; Figures 6D–6H).
For example, though we observed ISNb and SNa axon inhibitors specific for nitric oxide synthase (N-nitro-L-
arginine methylester [L-NAME]), xanthine oxidase (allo-guidance phenotypes consistent with MICAL LOF phe-
notypes (Figure 6D; Table 1), these phenotypes were purinol [Allo]), or mitochondrial electron transport
(NADH dehydrogenase; rotenone [Rote]) at concentra-often more severe. They include defects in which axons
bypass their muscle targets but then appear to defasci- tions previously shown to be effective in cell culture
conditions (Figure 7G). DRG axons and Sema3A-culate in inappropriate places and project into adjacent
segments (e.g., Figure 6D). Interestingly, we also ob- secreting 293 cells appeared normal following growth
in the presence of all but one of these inhibitors. In someserved ISNb and SNa axon guidance phenotypes con-
sistent with MICAL GOF, but these phenotypes also explants we noticed an adverse effect on survival of
DRGs treated with rotenone, but axons in those rote-appeared more severe (e.g., Figures 6E and 6F) and
included severely defasciculated and tangled axons none-treated explants that survived, although some-
what thinner than normal, were robustly repelled (Figure(Figures 6E). Finally, we saw phenotypes unlike MICAL
or PlexA LOF or GOF mutants, including axons pro- 7G). The amount and biological activity of Sema3A pro-
duced by 293 cells in the presence of all inhibitors wasjecting along the entire length of the muscle 6/7 cleft
(Figure 6G) and dramatic axonal wandering within mus- similar as assessed using a DRG growth cone collapse
assay (Figure 7B), showing that none of these inhibitorscle fields (e.g., Figure 6H). These phenotypes suggest
that expression of MICALG→W leads to defects not ex- had an adverse effect on the ability of 293 cells to pro-
duce active Sema3A. We also determined in separateplained by a simple elevation or diminution of PlexA
signaling activity. experiments that 25 M EGCG dramatically abrogates
Sema3A-mediated growth cone collapse in NGF-depen-In summary, these results show the necessity of an
intact flavoprotein monooxygenase domain for MICAL dent DRG neurons (Figure 7G). Taken together, our re-
sults support a role for flavoenzymes and oxidation-function in repulsive motor axon guidance.
reduction mechanisms in semaphorin-mediated repul-
sive axon guidance.Flavoprotein Monooxygenase Inhibitors
Neutralize Vertebrate Sema3A
Axonal Repulsion Discussion
The MICALs may be susceptible to small molecule inhib-
itors that affect their ability to oxidize their substrate. Neuronal growth cone guidance depends on the ability
of various guidance cue receptors to regulate cytoskele-Some gallic acid derivatives, including the green tea
component ()-epigallocatechin gallate (EGCG), are po- tal dynamics in response to the local presentation of
ligands. We show here that proteins belonging to thetent and selective inhibitors of two flavoprotein monoox-
ygenases: squalene epoxidase (SE) and p-hydroxyben- MICAL family of cytosolic, multidomain, flavoprotein
monooxygenases are required for certain plexin-medi-zoate hydroxylase (pHBH) (Abe et al., 2000a, 2000b).
All available evidence points to the plexin cytoplasmic ated semaphorin axon guidance events. MICALs associ-
ate with plexins and contain several conserved domainsdomain as an essential signal-transducing domain for
signaling class 3 semaphorin repulsion (Cheng et al., that provide the potential for interactions with both
growth cone cytoskeletal components and many signal-2001; Takahashi and Strittmatter, 2001). Sema3A ap-
pears to utilize neuropilin-1 in combination with A class ing proteins intimately involved in their regulation. Our
results suggest that MICALs directly participate in plexinplexins to signal repulsive guidance. To ask whether
selective flavoprotein monooxygenase inhibitors can signaling through the action of their flavoprotein mono-
oxygenase domain. These observations provide aneutralize semaphorin-mediated repulsion in verte-
brates, we employed an in vitro rat DRG growth cone framework for dissecting the molecular basis of sema-
phorin-meditated neuronal guidance and also a poten-repulsion assay using Sema3A-secreting 293 cells (Fig-
ure 7A; Messersmith et al., 1995). NGF-dependent DRG tial target for attenuating their repulsive action.
Our genetic and biochemical results support an es-axons exhibit little to no outgrowth toward Sema3A-
secreting 293 cell aggregates (Figures 7C and 7G). How- sential role for Drosophila MICAL in mediating PlexA/
Sema-1a repulsive guidance events required for motorever, when 25 M EGCG is added to the growth media,
Sema3A repulsion was completely neutralized (Figures axon pathfinding. Future experiments will establish
whether MICAL mediates PlexB signaling, and if so,7D and 7G). EGCG attenuation of Sema3A-mediated
repulsion is dose dependent (Figure 7G). We also asked whether this occurs directly or indirectly. Drosophila
MICAL is an ortholog of the previously characterizedwhether ()-epicatechin (EC), a compound structurally
MICAL Oxidoreductases and Plexin Repulsion
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Figure 7. Flavoprotein Monooxygenase In-
hibitors Attenuate Vertebrate Semaphorin
Axonal Repulsion
Inhibitors of flavoprotein monooxygenases
(EGCG and EC) as well as specific inhibitors
of other oxidation/reduction enzymes includ-
ing nitric oxide synthase (L-NAME), xanthine
oxidase (allopurinol [Allo]), and mitochondrial
electron transport (NADH dehydrogenase; ro-
tenone [Rote]) were tested for their ability to
inhibit semaphorin-dependent repulsive axon
guidance in vertebrates.
(A) E14/15 Rat DRG explants were cocultured
with 293 cells expressing Sema3A and grown
for 48 hr in the presence of an inhibitor or
vehicle. Axonal outgrowth was determined by
measuring proximal (P) and distal (D) axon
lengths.
(B) Redox inhibitors do not have adverse ef-
fects on expression of Sema3A or its biologi-
cal activity. Media was collected from un-
transfected 293 cells (No Sema3A) or cells
transfected with AP-Sema3A and grown in
the presence of vehicle (Sema3A), 25 M
EGCG (3A/EGCG), 500 M EC (3A/EC), 500
M L-NAME (3A/L-NAME), 500 M Allo (3A/
Allo), or 0.1 M Rote (3A/Rote), and ligand
concentration (AP activity) was determined.
The media was then diluted to 1 nM (to re-
move the active concentration of the inhibi-
tor) and its biological activity was assayed in
a growth cone collapse assay (percent col-
lapse; n  60 growth cones per condition).
The AP activity and percentage of growth
cones collapsed were similar in the presence
of all compounds.
(C–F) Sema3A-secreting 293 cells (asterisk)
potently repel DRG axons (C), but this effect
is neutralized when DRG explants are grown
in the presence of EGCG (D) or EC (E). No
effect on repulsion was observed in the pres-
ence of Allo (F).
(G) Quantification of the effects of oxidation/reduction enzyme inhibitors on Sema3A repulsion scored as the ratio of the axon lengths on the
proximal and distal sides of the explant (P/D ratio), and on Sema3A-mediated growth cone collapse indicated as percent collapsed growth
cones (green). In repulsion assays, outgrowth of DRG axons on the side distal to the 293 cells appeared normal. Attenuation of Sema3A-
mediated axonal repulsion was observed with the flavoprotein monooxygenase inhibitors (EGCG and EC) in a dose-dependent manner but
not with specific inhibitors of other oxidation/reduction enzymes. n equals number of DRG explants (repulsion assays) or number of growth
cones scored (collapse assays; distributed over four different explants/condition). For Rote, n 4; however, only 4 out of 12 explants survived.
(single asterisk indicates p  0.001; double asterisk indicates p  0.0001; paired t test). Scale bar equals 550 m.
mammalian MICAL-1 protein (Suzuki et al., 2002), and binding monooxygenase domains required for mediat-
ing plexin signaling. In support of this idea, we observedwe show here that there are at least three vertebrate
MICAL orthologs (MICALs 1, 2, and 3). We also iden- that inhibition of flavoprotein monooxygenase enzy-
matic activity dramatically attenuates semaphorin-tify here a family of MICAL-like proteins that lack the
conserved N-terminal MICAL monooxygenase domain. mediated axon repulsion and growth cone collapse.
However, though the inhibitor EGCG has a high degreeOur expression and interaction data support the idea
that MICALs mediate plexin signaling in vertebrates. In of selectivity for flavoprotein monooxygenases, similar
concentrations of EGCG inhibit other enzymes includingaddition, flavoprotein monooxygenase inhibitors block
Sema3A-mediated repulsion and collapse of NGF- steroid 5-reductase, NADPH-cytochrome P450 reduc-
tase, telomerase, matrix metalloproteinases MMP-2 anddependent DRG axons, repulsive interactions depen-
dent on A class plexins including plexin A3. Future ge- MMP-9, and phenol sulfotransferase (Abe et al., 2000a,
2000b). Although most of these enzymes are unlikely tonetic and biochemical analysis will establish the role of
vertebrate MICALs in neuronal and nonneuronal plexin be expressed in the growth cones of DRG axons, we
cannot rule out potential nonspecific effects of thesesignaling.
The highly conserved 500 amino acid N-terminal inhibitors despite their demonstrated selectivity for
monooxygenases. Taken together with our in vivo Dro-MICAL domain contains signature amino acid se-
quences of the flavoprotein monooxygenase family of sophila experiments showing a requirement for the MI-
CAL FAD binding region in Sema-1a-mediated axon re-oxidoreductases. Our biochemical and genetic analyses
strongly suggest that MICALs contain functional FAD pulsion, these data suggest redox signaling plays an
Cell
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Experimental Proceduresimportant role in vertebrate semaphorin-mediated axo-
nal repulsion.
Yeast Two-Hybrid ScreeningFlavoprotein monooxygenases specifically catalyze
Yeast protocols were conducted using standard techniques (Go-
the oxidation of a number of substrates, and in some lemis et al., 1994). Portions of the intracellular domains of PlexA
contexts they can function as oxidases and generate (amino acids 1702–1945; EST LD13083), PlexB (amino acids 1785–
2051; EST CK00213), and the corresponding intracellular regionsreactive oxygen species (Massey, 1994). Our results
of human Plexin A3 and mouse Plexin A4 (gifts of L. Tamagnone andsuggest that MICALs are flavoproteins most similar to
H. Fujisawa, respectively) were inserted into the yeast bait vector.the flavoprotein monooxygenase family of oxidoreduc-
cDNAs containing the C-terminal of human MICAL-1 (DFkzp434B517)tases, but a complete understanding of the chemical
and mouse MICAL-2 (BB481898) were used to amplify portions ho-
nature of the reactions catalyzed by MICALs awaits fu- mologous to the last 200 amino acids of Drosophila MICAL and
ture study and identification of substrates. The redox cloned into the library vector.
regulation of amino acid residues within signaling pro-
Molecular Analysisteins (including kinases, phosphatases, small GTPases,
Proteins, domains, and alignments were identified using Web-basedguanylate cyclases, and adaptor proteins) and cytoskel-
protein domain searching and alignment tools (PFAM, BLAST,etal proteins (including actin, actin binding proteins, in-
PRINTS, JALVIEW, and ClustalX) and our own molecular analysis.
termediate filament proteins, and GAP-43) has been Human MICAL-1 (EST FLJ11937), human MICAL-2 (ESTs KIAA0750
shown to modulate their function (Finkel, 1998; Kim et and FLJ14966), and human MICAL-3 (ESTs BF815128, KIAA1364,
al., 2002; Meng et al., 2002; Rhee et al., 2000; Stamler and KIAA0819) were identified by BLAST searches on publicly avail-
able cDNA, and genomic sequence and in some cases overlappinget al., 2001; Thannickal and Fanburg, 2000). In addition,
ESTs were assembled virtually. Drosophila MICAL-L (EST LD45758)oxidation of actin leads to disassembly of actin fila-
and human MICAL-L1 (EST XM001070) and MICAL-L2 (ESTSments, instability and collapse of actin networks, re-
FL00139 and FLJ23471) were identified by searching publicly avail-
duced ability of actin to interact with actin crosslinking able cDNA and genomic sequence databases.
proteins, and a decrease in the ability of actin monomers
to form polymers (Dalle-Donne et al., 2001a, 2001b; Mil- In Situ Hybridization
zani et al., 1997). Finally, it is also interesting that MICALs RNA in situ analysis of whole-mount Drosophila embryos and cryo-
sections of E15 and E18 rat spinal cords were as described (Kolodkinhave a putative actin filament binding domain (CH do-
et al., 1993; Pasterkamp et al., 1998).main) and that MICAL-1 interacts with vimentin, an inter-
mediate filament protein (Suzuki et al., 2002).
MICAL Antibody Generation, Western Analysis,It was recently reported that the proline-rich region
Immunohistochemistry, and Immunoprecipitation
of vertebrate MICAL-1 interacts with the SH3 domain of Antibodies were generated and characterized as described (Yu et
the adaptor protein CasL (HEF1) in nonneuronal cells al., 1998). cDNAs corresponding to the last 359 aa of MICAL (MICAL-
CT antibody) were inserted into the pTrcHisA vector (Invitrogen).(Suzuki et al., 2002). CasL, along with the related pro-
MICAL-CT antibodies were used for Western analysis at a 1:2000teins p130Cas and Efs (Sin), make up the Cas family
dilution and on Drosophila embryos at a 1:3000 dilution.of proteins (O’Neill et al., 2000), which assemble and
Embryos generated by crossing UAS-HAPlexA and Elav-GAL4/transduce intracellular signals that stimulate cell migra-
Cyo adults were collected, and coimmunoprecipitations were per-
tion and axon outgrowth. These proteins have numerous formed using standard techniques (see Supplemental Data at http://
protein-protein interaction domains, including a Src- www.cell.com/cgi/content/full/109/7/887/DC1) and an HA mono-
clonal antibody (12CA5; Roche). Western analysis was performedhomology 3 (SH3) domain, multiple SH2 binding sites in
using an HA antibody (1:3000, rat mAb Clone 3F10, Roche), ourtheir substrate domain, several proline-rich motifs, and
MICAL-CT antibody (1:2000), and an Enabled antibody (1:500;a C-terminal dimerization module. This structure sug-
IG6C10; gift from D. VanVactor).gests a role for Cas family proteins as docking mole-
cules, and numerous interacting proteins have been Drosophila Genetics and Phenotypic Characterization
identified, including kinases (e.g., FAK, Src, and Abl), Drosophila genetics, transformations, and preparation and analyses
phosphatases (e.g., PTP-1B and SHP2), GEFs (e.g., of Drosophila embryos was performed as described (Winberg et al.,
1998b; Yu et al., 1998; see Supplemental Data at http://www.cell.C3G), and adaptor proteins (e.g., Nck, Crk, Grb2, and
com/cgi/content/full/109/7/887/DC1).14-3-3) (O’Neill et al., 2000). Studies indicate that Cas
proteins localize mainly to focal adhesions and stress
Vertebrate In Vitro Repulsion and Collapse Assaysfibers and that they are required in integrin-dependent
DRG repulsion assays were performed as described (Messersmith
cell migration and actin filament assembly. Cas proteins, et al., 1995). EGCG, EC, L-NAME, and allopurinol (Sigma) were dis-
therefore, may play an important role in plexin-mediated solved in vehicle (PBS), protected from light, and then added to
repulsive and attractive guidance events. the culture media to final concentrations. Rotenone (Sigma) was
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axonal repulsion. Our results also suggest that protein Purification and FAD Binding
oxidation could be a general means for inhibiting axonal His-tagged bacterial fusion protein comprised of the MICAL flavo-
protein monooxygenase domain (MICAL-FM) was made by insertinggrowth. Given the presence of high amounts of reactive
amino acids 1–526 of Drosophila MICAL into the bacterial expres-oxygen species and other oxidants in the spinal cord
sion vector pET 43.1b (Novagen). MICAL-FM was isolated with theafter injury (Juurlink and Paterson, 1998), regulation of
inclusion bodies, denatured with 6 M GdmHCl (GIBCO), and purified
redox signaling using antioxidants and specific enzyme under denaturing conditions over a Ni2 column (Novagen). MICAL-
inhibitors may be a powerful approach for encouraging FM was renatured as described (Lindsay et al., 2000; see Supple-
mental Data) and repurified over a Ni2 column. Spectral analysisaxonal regeneration.
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